Booth No.5N-16
CategoryOutsourcing

Genovior Biotech Corporation

Booth No.:5N-16
Category:Outsourcing
Company Information
Email: contact@genovior.com.tw TEL: Address: 35053
4F, 50-8, Keyan Road, Zhunan Township Taiwan 35053 TAIWAN
URL: https://www.genovior.com.tw/
Genovior is a dedicated CDMO focus on process development, scale up, formulation development, and productivity optimization under PIC/S GMP (cGMP, EU GMP) for our customers worldwide. Our one-stop services conveniently provide effective and efficient solution and our non-competition policy provides maximum security and protection in IP for our clients.

Genovior Biotech Corp. is a vertically integrated contract development and manufacture company, providing following services:
(a) process development of peptide or protein biologics from microbial or human recombinant fermentation processes
(b) formulation development of biological injectables
(c) manufacturing capacities of biologics, lyophilized injectable, and prefilled syringe/cartridge for preclinical, clinical, and commercial uses

Company information

Address 35053
4F, 50-8, Keyan Road, Zhunan Township Taiwan 35053 TAIWAN
URL https://www.genovior.com.tw/
Email contact@genovior.com.tw
Product Classification Contract Manufacturing (CDMO/CMO) API
Contract Manufacturing (CDMO/CMO) Injectables
Pemetrexed Injection; 100mg & 500mg (Swissmedic & TFDA approved)
Bortezomib Injection; 3.5mg (TFDA approved)
Doxorubicin Injection; 10mg (TFDA approved)
Docetaxel Injection; 20mg/mL (1mL/vial) (TFDA approved)
Fulvestrant Injection; 250mg (TFDA approved)
Gemcitabine Injection; 200mg (TFDA approved)
Azacitidine Injection; 100mg (TFDA approved)
Gemcitabine Injection; 200mg (TFDA approved)
Ganciclovir Injection; 500mg (TFDA approved)
Fulvestrant (API)
Octreotide (API)
Pemetrexed (API)
Teriparatide (API)
Azacitidine (API)
Bortezomib (API)
Semaglutide Injection (in development)New
Carfilzomib Injection (in development)New
Teriparatide Injection (in development)

Product introduction

Contract Manufacturing (CDMO/CMO) APIContract Manufacturing (CDMO/CMO) InjectablesPemetrexed Injection; 100mg & 500mg (Swissmedic & TFDA approved)Bortezomib Injection; 3.5mg (TFDA approved)Doxorubicin Injection; 10mg (TFDA approved)Docetaxel Injection; 20mg/mL (1mL/vial) (TFDA approved)Fulvestrant Injection; 250mg (TFDA approved)Gemcitabine Injection; 200mg (TFDA approved)Azacitidine Injection; 100mg (TFDA approved)Gemcitabine Injection; 200mg (TFDA approved)Ganciclovir Injection; 500mg (TFDA approved)Fulvestrant (API)Octreotide (API)Pemetrexed (API)Teriparatide (API)Azacitidine (API)Bortezomib (API)Semaglutide Injection (in development)NewCarfilzomib Injection (in development)NewTeriparatide Injection (in development)